Clinical Trial Update: Von Willebrand Factor Concentrate During ECMO Support [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on von Willebrand factor concentrate during ECMO support for acquired von Willebrand disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Von Willebrand Disease

Snippet

Sponsor: Tirol Kiniken GmbH | Conditions: Acquired Von Willebrand Disease | Phase 2 | Status: UNKNOWN